media – Page 561 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

4 causes of failure for medical devices

Materials are one of the most common causes of failure in medical devices, especially for plastic. Records show that material failure is responsible for 30 to 40 percent of all FDA recalls on medical devices.
- Source: multibriefs
- 567
- February 12, 2018
Market Views medical device
Best tech tools to communicate with patients? Time for doctors to ask

Cultivating a strong relationship with patients can translate into higher satisfaction scores but there is a widespread failure to communicate about the most appropriate way to reach consumers.
- Source: healthcareitnews
- 453
- February 12, 2018
healthcare Market Views
Major fertility breakthrough as human eggs grown in lab for first time

Human eggs have been fully grown in a laboratory for the first time in what has been hailed as a majorfertility breakthrough.
- Source: msn
- 494
- February 11, 2018
Human eggs majorfertility Researches
Genentech’s Tecentriq Impresses Again in Late-Stage Kidney Cancer Trial

Genentech’s PD-L1 inhibitor Tecentriq continues to show off its versatility. Monday, the Roche subsidiary announced a combination of Tecentriq and Avastin (bevacizumab) was significantly beneficial to patients with advanced or metastatic renal cell carcinoma (mRCC) who have not received prior systemic active or experimental therapy.
- Source: Biospace
- 658
- February 11, 2018
Clinical Trial inhibitor mRCC Tecentriq
Scientists discover way to halt breast cancer spread

Scientists have uncovered a key mechanism that facilitates the spread of breast cancer cells, and thus a potential target for new therapeutic approaches in the fight against the disease.
- Source: pharmatimes
- 528
- February 11, 2018
breast cancer L-asparaginase Researches
Janssen Enters Into Worldwide Collaboration With Theravance Biopharma For Oral, Pan-JAK Inhibitor Drug Candidate For The Treatment Of Inflammatory Bowel Disease

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today their entry into a worldwide collaboration with an affiliate of Theravance Biopharma, Inc. to develop TD-1473, a first-in-class oral, gastrointestinal (GI) restricted pan-Janus kinase (JAK) inhibitor for the treatment of inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis (UC).
- Source: prnewswire
- 599
- February 11, 2018
Crohn’s disease IBD Janssen Johnson & Johnson ulcerative colitis
Stanford spin-out Zenflow raises $31M to join the megamarket for enlarged prostate

A San Francisco, California-based medical device startup, Zenflow, has announced a $31.4 million Series A financing round to further its minimally-invasive approach to treating benign prostatic hyperplasia (BPH) or enlarged prostate.
- Source: MedCityNews
- 725
- February 11, 2018
FDA financing Market Views prostate
Kinsa launches QuickCare, an FDA-cleared wireless connected thermometer

Smart thermometer and connected health company Kinsa has launched a new wireless version of its device, called Kinsa QuickCare, after securing FDA clearance last month.
- Source: MobileHealthNews
- 877
- February 11, 2018
Company Insight digital health FDA mHealth
chemoWave app offers patients support during chemotherapy

Following a soft launch last year, the chemoWave disease companion app has now been fully released for chemotherapy patients interested in better managing their care, symptoms, and side effects.
- Source: MobiHealthNews
- 577
- February 11, 2018
Chemotherapy Company Insight digital health mHealth
Paige.AI Created to Transform Cancer Diagnosis and Treatment by Applying Artificial Intelligence to Pathology

Paige.AI, a new company focused on revolutionizing clinical diagnosis and treatment in oncology through use of artificial intelligence (AI), launches today as it announces two major milestones
- Source: tmcnet
- 563
- February 9, 2018
AI Market Views Series

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.